Citation Impact
Citing Papers
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial
2005
Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin
2012 Standout
Chemotherapy for Falciparum Malaria: The Armoury, the Problems and the Prospects
2000
Traditional use of medicinal plants in south-central Zimbabwe: review and perspectives
2013 Standout
From traditional Chinese medicine to rational cancer therapy
2007 Standout
Determining Important Parameters in the Spread of Malaria Through the Sensitivity Analysis of a Mathematical Model
2008 Standout
Antimalarial Activity of Radicicol. Heptelidic Acid and Other Fungal Metabolites.
1998 StandoutNobel
Natural products: A continuing source of novel drug leads
2013 Standout
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study
2000
Counterfeit anti-infective drugs
2006 Standout
Substituted benzo[i]phenanthridines as mammalian topoisomerase-Targeting agents
2003
Acylated pregnane glycosides from Caralluma tuberculata and their antiparasitic activity
2008 StandoutNobel
Nanotechnology as a therapeutic tool to combat microbial resistance
2013 Standout
Chemical biology of natural indolocarbazole products: 30 years since the discovery of staurosporine
2009 StandoutNobel
Murine Cerebral Malaria Development Is Independent of Toll-Like Receptor Signaling
2007 StandoutNobel
Pathogenesis, clinical features, and neurological outcome of cerebral malaria
2005
Two New Components of the Aspochalasins Produced by Aspergillus sp.
1997 StandoutNobel
Elucidating biosynthetic pathways for vitamins and cofactors
2007
Artemisinins: mechanisms of action and potential for resistance
2004
Heme-dependent Radical Generation. Possible Involvement in Antimalarial Action of Non-peroxide Microbial Metabolites, Nanaomycin A and Radicicol.
1999 StandoutNobel
The Transcriptome of the Intraerythrocytic Developmental Cycle of Plasmodium falciparum
2003 Standout
Diagnostics for the developing world
2004 Standout
Recent advances in the transition metal-catalyzed twofold oxidative C–H bond activation strategy for C–C and C–N bond formation
2011 Standout
Cycloguanil and Its Parent Compound Proguanil Demonstrate Distinct Activities against Plasmodium falciparumMalaria Parasites Transformed with Human Dihydrofolate Reductase
1998
Biological roles of glycans
2016 Standout
Making malaria treatment policy in the face of drug resistance
1999
Global malaria mortality between 1980 and 2010: a systematic analysis
2012 Standout
Plectranthus: A review of ethnobotanical uses
2005 Standout
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
2014 Standout
Epidemiology of drug-resistant malaria
2002
Malaria
2013 Standout
Studies on Coumarins and Coumarin-Related Compounds to Determine their Therapeutic Role in the Treatment of Cancer
2004 Standout
Malaria in 2002
2002 Nature
The pathogenic basis of malaria
2002 StandoutNature
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Effects of Early Cerebral Malaria on Cognitive Ability in Senegalese Children
2002
Antitrypanosomal activity of some pregnane glycosides isolated from Caralluma species
2009 StandoutNobel
Antimicrobial resistance in developing countries. Part II: strategies for containment
2005
Molecular epidemiology of malaria in Cameroon
2007
Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial
2003
Antimalarial drug synergism and antagonism: Mechanistic and clinical significance
2005
Screening of Thai medicinal plant extracts and their active constituents forIn Vitro antimalarial activity
2006 StandoutNobel
Child development: risk factors for adverse outcomes in developing countries
2007 Standout
4-Aminoquinoline Based Molecular Hybrids as Antimalarials: An Overview
2014
Cost-Effectiveness Study of Three Antimalarial Drug Combinations in Tanzania
2006
Mutations in the P. falciparum Digestive Vacuole Transmembrane Protein PfCRT and Evidence for Their Role in Chloroquine Resistance
2000 Standout
Antiparasitic properties of medicinal plants and other naturally occurring products
2001
Population Pharmacokinetics of Intramuscular Artesunate in African Children With Severe Malaria: Implications for a Practical Dosing Regimen
2013
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Medical need, scientific opportunity and the drive for antimalarial drugs
2002 Nature
Seizures and status epilepticus in childhood cerebral malaria
1996
A marker for Stevens–Johnson syndrome
2004 StandoutNature
Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine
2013
Investigation of some medicinal plants traditionally used for treatment of malaria in Kenya as potential sources of antimalarial drugs
2010
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa
2012 Standout
A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry
2014 Standout
Markers of Sulfadoxine-Pyrimethamine-Resistant Plasmodium falciparum in Placenta and Circulation of Pregnant Women
2006
Annona muricata (Annonaceae): A Review of Its Traditional Uses, Isolated Acetogenins and Biological Activities
2015 Standout
Biologically active quinoline and quinazoline alkaloids part II
2018
Quantitative proteomics of the human malaria parasite Plasmodium falciparum and its application to studies of development and inhibition
2004
Heme-dependent Radical Generation from Antimalarial Fungal Metaholites, Radicicol and Heptelidic acid.
1998 StandoutNobel
Quantitative Proteomic Profiling of Host−Pathogen Interactions: The Macrophage Response to Mycobacterium tuberculosis Lipids
2008 StandoutNobel
The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden
2001 Standout
Overview of pharmacological activities ofAndrographis paniculataand its major compound andrographolide
2018 Standout
Homologation of the Fischer Indolization: A Quinoline Synthesis via Homo‐Diaza‐Cope Rearrangement
2020 StandoutNobel
Catalytic, Asymmetric Transannular Aldolizations: Total Synthesis of (+)-Hirsutene
2008 StandoutNobel
Medicinal Plants of the Washambaa (Tanzania): Documentation and Ethnopharmacological Evaluation
2000
Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine
2011
Dihydropteroate Synthase Mutations in Pneumocystis jiroveci Can Affect Sulfamethoxazole Resistance in a Saccharomyces cerevisiae Model
2004
Qinghaosu (Artemisinin): The Price of Success
2008 Science
Antimalarial drug discovery: old and new approaches
2003
Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy
1996 Standout
Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil
1997
Status of antimalarial drugs under development.
1995
Point-of-Care Diagnostics for Global Health
2008 Standout
Association of Transmission Intensity and Age With Clinical Manifestations and Case Fatality of Severe <EMPH TYPE="ITAL">Plasmodium falciparum</EMPH> Malaria
2005
Nitroarylstannanes as Synthons for the Preparation of Phenanthridine and Benzo[i]phenanthridine Derivatives
2000
Antimalarial drug resistance and combination chemotherapy
1999
Chemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like Reactions
2018 Standout
Medicine Sellers and Malaria Treatment in Sub-Saharan Africa: What Do They Do and How Can Their Practice Be Improved?
2007 Standout
The de novo selection of drug–resistant malaria parasites
2003
Cutaneous Drug Reactions
2001
Aryl−Aryl Bond Formation One Century after the Discovery of the Ullmann Reaction
2002 Standout
Drug Resistance in Leishmaniasis
2006 Standout
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer
2020 Standout
Generation of Anti-trypanosomal Agents through Concise Synthesis and Structural Diversification of Sesquiterpene Analogues
2011 StandoutNobel
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Works of E.K. Mberu being referenced
Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania
2001
The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study
1997
Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance
2002
Pyrimethamine–sulfadoxine resistance in Plasmodium falciparum: what next?
2001
Japanese poor metabolizers of proguanil do not have an increased risk of malaria chemoprophylaxis breakthrough
1995
Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: the importance of unbound quinine concentration
1993
The antimalarial triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug.
1999
Molecular Evidence of Greater Selective Pressure for Drug Resistance Exerted by the Long‐Acting Antifolate Pyrimethamine/Sulfadoxine Compared with the Shorter‐Acting Chlorproguanil/Dapsone on KenyanPlasmodium falciparum
2000
Genetic diversity of Plasmodium falciparum parasites from Kenya is not affected by antifolate drug selection
2002
A new antiplasmodial coumarin from Toddalia asiatica roots
2000
The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses
1997
Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: unbound quinine concentrations following a simple loading dose regimen
1994
Ferriprotoporphyrin catalysed decomposition of artemether: Analytical and pharmacological implications
1994
Antimalarial activity in crude extracts of Malawian medicinal plants
1996
The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya.
2000
More on ‘The Efficacy of Antifolate Antimalarial Combinations in Africa'
1999
Cutaneous hypersensitivity reactions to thiacetazone, HIV infection and thiacetazone concentrations in plasma
1996
Inter-individual variation in the metabolic activation of the antimalarial biguanides
1991
Kenyan Plasmodium falciparum Field Isolates: Correlation between Pyrimethamine and Chlorcycloguanil Activity In Vitro and Point Mutations in the Dihydrofolate Reductase Domain
1998
The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non‐severe falciparum malaria.
1992
Prophylactic phenobarbitone in young children with severe falciparum malaria: pharmacokinetics and clinical effects.
1992
In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs
1995
Inter‐subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man.
1989
Potent antimalarial activity of the alkaloid nitidine, isolated from a Kenyan herbal remedy
1995
Towards an Understanding of the Mechanism of Pyrimethamine-Sulfadoxine Resistance in Plasmodium falciparum : Genotyping of Dihydrofolate Reductase and Dihydropteroate Synthase of Kenyan Parasites
2000